The "fiber gap" refers to the gap between the recommended amount of fiber intake and the actual amount of fiber consumed in the average person's diet—and it's estimated that most people are lacking at least 10 grams of fiber per day in their diet. PharmaBiome and Roquette are partnering up to design innovative prebiotics with predictive microbiome technology.
This partnership will see PharmaBiome’s proprietary NicheMap technology used to screen and formulate prebiotics using soluble fibers developed by Roquette. As detailed in a press release, PharmaBiome's unique predictive microbiome technology NicheMap has "demonstrated strong capabilities to predict the effect of prebiotic fibers on both microbial composition and activity in the human gut." Ultimately, Roquette will be able to offer new microbiome-targeted fibers with scientifically proven health benefits.
Microbiome-Targeted Fibers
PharmaBiome and Roquette are Teaming Up to Reduce the Fiber Gap
Trend Themes
1. Microbiome-targeted Fibers - PharmaBiome and Roquette are using microbiome screening technology to develop new prebiotic fibers with scientifically-proven health benefits.
2. Reducing Fiber Gap - Addressing the fiber gap in people's diets by developing innovations in prebiotic fiber technology has considerable space for market disruption.
3. Predictive Microbiome Technology - With more research and technological innovation, predictive microbiome technology can revolutionize how we think about gut health and nutrition.
Industry Implications
1. Food and Beverage - The food and beverage industry can innovate by integrating prebiotic fibers into their products and promoting the health benefits of fiber intake.
2. Pharmaceutical - Pharmaceutical companies can explore microbiome screening technology to develop personalized therapies and medications for gut-related illnesses and diseases.
3. Biotech - Biotech companies can invest in research and development of innovative prebiotic fibers and microbiome screening technology to disrupt the food, beverage, and pharmaceutical industries.